02373.HK
Beauty Farm Medical and Health Industry Inc.
HKSE · Healthcare · Medical - Care Facilities · CN
HKD 17.45
−1.97%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 5.6B | 3.0B | 2.6B | 2.1B | 1.6B |
| Cost of Revenue | 2.9B | 1.5B | 1.4B | 1.2B | 917.6M |
| Gross Profit | 2.7B | 1.5B | 1.2B | 977.1M | 717.8M |
| Operating Expenses | |||||
| R&D Expense | 78.0M | 41.9M | 36.0M | 34.1M | 31.2M |
| SG&A Expense | 1.8B | 992.7M | 849.8M | 166.9M | 171.1M |
| General & Admin Expense | 865.0M | 477.0M | 388.1M | 31.5M | 60.4M |
| Selling & Marketing Expense | 976.5M | 514.7M | 461.7M | 135.4M | 110.7M |
| Other Expenses | (39.3M) | (22.3M) | (17.7M) | 484.9M | 363.4M |
| Total Operating Expenses | 1.9B | 1.0B | 868.2M | 685.8M | 565.7M |
| Cost and Expenses | 4.8B | 2.5B | 2.3B | 1.9B | 1.5B |
| Operating Income (EBIT) | 781.3M | 459.5M | 321.8M | 291.3M | 152.1M |
| Non-Operating | |||||
| Interest Income | 49.1M | 22.7M | 23.6M | 21.8M | 3.1M |
| Interest Expense | 36.4M | 32.2M | 27.6M | 24.8M | 24.7M |
| Net Interest Income | (13.5M) | (9.4M) | (3.9M) | (3.0M) | (21.6M) |
| Other Non-Op Income/Expense | (13.4M) | (9.4M) | (3.9M) | (3.0M) | (21.6M) |
| Non-Operating Income (excl Interest) | 19.4M | 7.7M | 11.7M | (21.8M) | (3.1M) |
| EBT (Pre-Tax Income) | 767.9M | 450.1M | 317.9M | 288.3M | 130.5M |
| Income Tax Expense | 175.2M | 109.8M | 65.4M | 58.1M | 19.9M |
| Bottom Line | |||||
| Net Income | 546.0M | 317.6M | 228.5M | 215.7M | 103.1M |
| Earnings from Cont. Ops | 592.8M | 340.3M | 252.5M | 230.1M | 110.5M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 546.0M | 317.6M | 228.5M | 215.7M | 103.1M |
| Per Share | |||||
| Basic EPS | HK$2.36 | HK$1.38 | HK$0.99 | HK$0.94 | HK$0.45 |
| Diluted EPS | HK$2.36 | HK$1.37 | HK$0.99 | HK$0.94 | HK$0.45 |
| Revenue Per Share | HK$23.89 | HK$12.94 | HK$11.20 | HK$9.35 | HK$7.09 |
| Shares | |||||
| Basic Shares Outstanding | 233.2M | 231.8M | 229.8M | 229.4M | 230.6M |
| Diluted Shares Outstanding | 233.2M | 231.9M | 229.8M | 230.1M | 230.6M |
| Profitability Metrics | |||||
| EBITDA | 1.0B | 603.5M | 427.5M | 644.8M | 452.4M |
| D&A | 264.5M | 151.7M | 117.3M | 331.7M | 297.2M |
| EBIT | 761.9M | 451.8M | 310.1M | 313.1M | 155.2M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2025